Search Results
Sep 10, 2025, 08:00 ET Gen Z and Millennial Patients with Chronic Rheumatic Diseases Are Opening Up to Raise Awareness for Improved Care
Surgery in Psoriatic Arthritis: Prevalence and Risk Factors. J Rheumatol. 2023:50(4);497–503.Deodhar A. Understanding Axial Spondyloarthritis: A Primer for Managed Care. Am J Manag Care. 2019;25:S319–30.Reveille J, Witter J, Weisman M. Prevalence of axial spondylarthritis in the
More news about: UCB
Sep 10, 2025, 08:00 ET Dermalogica PRO Secures FDA 510(k) Clearance for Next-Generation PRO Pen Microneedling System, Ushering in a New Era of Skin Health Innovation
and our clinical partners at our parent company, Unilever (UL) for their support and guidance"- Robert J. Bianchini, Ph.D., AAD, Vice-President Technology & Innovation As consumer preference rises for less invasive, evidence-backed treatments
More news about: Dermalogica
Sep 10, 2025, 07:15 ET Witness How Animals Adapt to a Changing World in a New Season of Nature, Wednesday, October 22 on PBS
W. Cassidy Foundation, Filomen M. D'Agostino Foundation, Gregg Peters Monsees Foundation, Koo and Patricia Yuen, Seton J. Melvin, Sandra Atlas Bass, and public television viewers. Websites:
More news about: The WNET Group
Sep 10, 2025, 07:00 ET Karyopharm Announces Completion of Enrollment in the Phase 3 SENTRY Trial in Myelofibrosis
G.A., Elli, E.M. et al. Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis. Blood Cancer J. 11, 4 (2021).3. Pardanani, A., & Tefferi, A. (2011). Prognostic relevance of anemia and transfusion dependency in myelodysplastic
More news about: Karyopharm Therapeutics Inc.
Sep 10, 2025, 03:00 ET JuCoin Rewrites the Impossible and Transforms into Ju.com
Ju.com's groundbreaking J symbol that functions as both brand logo and transformation tool. When used as an apostrophe in "Rewrite I[J]mpossible," the geometric J literally converts impossibility into possibility, providing visual proof of the platform's core philosophy. "Our J symbol does exactly
More news about: Ju.com
Sep 09, 2025, 19:01 ET Flagship REIT Strengthens Capital Position With Expansion of Senior Revolving Credit Facilities
syndicated credit facility represents a major step forward in Flagship's evolution," said President and Chief Executive Officer J. Brannen Edge III. "Moving to a semi-unsecured structure provides us with additional flexibility and demonstrates our lending partners' recognition
More news about: Flagship Healthcare Properties
Sep 09, 2025, 18:18 ET AIChE Recognizes Outstanding Achievements with 2025 Institute and Board of Directors' Awards
Professor, Purdue University, Davidson School of Chemical Engineering, will receive the F. J. and Dorothy Van Antwerpen Award for Service to AIChE. The award is sponsored by The Dow Chemical Company. Dr. Milad Abolhasani, ALCOA
More news about: American Institute Of Chemical Engineers
Sep 09, 2025, 17:00 ET AGNICO EAGLE ANNOUNCES ADDITIONAL INVESTMENT IN MAPLE GOLD MINES LTD.
Maple's head office is located at 1111 West Hastings Street, 6th Floor, Vancouver, British Columbia V6E 2J3. About Agnico Eagle Canadian-based and led, Agnico Eagle is Canada's largest mining company and
More news about: Agnico Eagle Mines Limited
Sep 09, 2025, 16:18 ET U.S. FDA approval of INLEXZO™ (gemcitabine intravesical system) set to transform how certain bladder cancers are treated
J&J withMe provides a simple, comprehensive patient support program offering cost support, a dedicated Care Navigator and educational resources, at
More news about: Johnson & Johnson
Sep 09, 2025, 16:10 ET Camden National Corporation Announces Succession for Chair of its Board of Directors
Marie J. McCarthy appointed to Vice-Chair of the Board and to succeed Lawrence J. Sterrs as Chair of the Board upon his retirement. CAMDEN, Maine,
More news about: Camden National Corporation
Sep 09, 2025, 14:10 ET What You Should Ask About Rehab: Just in Time for National Recovery Month
that it helps people and their families feel less alone, more prepared, and more willing to say yes to help." Dr. Patrick J. Carnes, world-renowned expert on sex addiction and treatment and author of The Betrayal Bond and Out of the Shadows, praised the
More news about: Meadows Behavioral Healthcare
![Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS])](https://mma.prnewswire.com/media/633165/PTx_updated_logo.jpg?w=300){kind=logo}
Sep 09, 2025, 13:42 ET Partner Therapeutics Receives EMA Approval of IMREPLYS® (sargramostim, rhu GM-CSF) to Treat Exposure to Myelosuppressive Doses of Radiation (Hematopoietic Sub-syndrome of Acute Radiation Syndrome [H-ARS])
doi:10.1148/radiol.09090330Dainiak N. Medical management of acute radiation syndrome and associated infections in a high-casualty incident. J Radiat Res. 2018;59(Suppl_2):ii54-ii64.
More news about: Partner Therapeutics, Inc.
Sep 09, 2025, 10:20 ET Lectron NACS & CCS Fast-Charging Adapters Pass UL 2252 Testing
benchmarks for electrical safety, thermal performance, and mechanical durability. As the EV industry moves toward broader adoption of the NACS (SAE J3400) connector, interoperability between charging standards is critical. Lectron's certified adapters support this transition by allowing EV drivers to
More news about: Lectron
Sep 09, 2025, 10:01 ET BROWN & WEINRAUB, NEW YORK'S TOP LOBBYING FIRM, EXPANDS WITH THE ADDITION OF THE AWARD-WINNING LAND USE AND ZONING PRACTICE TEAM FROM THE FORMER LOBBYING FIRM OF CAPALINO & CO.
Department of General Services and the Public Development Corporation and currently serves in leadership roles in several organizations including the Samuel J. Tilden Democratic Club and the Stonewall Democratic Club. As the former Chair of Manhattan Community Board Six, Mark
More news about: BROWN & WEINRAUB
Sep 09, 2025, 09:05 ET NICU Awareness Month Milestone: 125,000 Preemies Helped by Prolacta Bioscience's 100% Breast Milk-Based Nutrition
Med. 2020;15(5):304-311. doi:10.1089/bfm.2019.0210Chou FS, Zhang J, Villosis MFB, et al. Exclusive human milk diet is associated with lower risk of motor function impairment at three years of corrected age. J Perinatol. 2025. doi:10.1038/s41372-025-02296-z
More news about: Prolacta Bioscience
Sep 09, 2025, 09:00 ET Arthur J. Gallagher & Co. Acquires Bremer Insurance Agencies, Inc.
our retail brokerage offerings in the Upper Midwest," said J. Patrick Gallagher, Jr., Chairman and CEO. "I am very pleased to welcome Travis and his associates to Gallagher." Arthur J. Gallagher & Co. (NYSE:AJG), a global insurance
More news about: Arthur J. Gallagher & Co.
Sep 09, 2025, 09:00 ET Parkinson's Advocates Rally in D.C., Urge Congress to Boost Research Funding & Ban Parkinson's-Linked Chemical
policy and government affairs officer at The Michael J. Fox Foundation. "The unified voice of Parkinson's advocates — patients, families and care partners — is critical to bringing urgency and humanity to every congressional decision. At The Michael J. Fox Foundation, we're proud to stand with thousands
More news about: The Michael J. Fox Foundation for Parkinson's Research
Sep 09, 2025, 09:00 ET Experience Nature's Masterpieces in Motion with a New Video Series on Wild Birds from the Cornell Lab of Ornithology
https://hubs.la/Q03C7J370 "We are thrilled to partner with OM SYSTEM on this exciting video series," says Justin Cleveland,
More news about: OM System
Sep 09, 2025, 08:49 ET CompassX Named One of Consulting Magazine's "Best Firms to Work For" in 2025 - Third Consecutive Year
honor, having previously been recognized in 2023 and 2024. "This year's award belongs to all of our employees," said Kyle J. Heppenstall, President and Founder of CompassX Consulting. "We've built a culture that values autonomy, growth, and balance. At CompassX, consultants
More news about: CompassX
Sep 09, 2025, 08:00 ET Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain health
doi:10.1002/alz.70235Porsteinsson AP, Isaacson RS, Knox S, et al. Diagnosis of early Alzheimer's disease: clinical practice in 2021. J Prev Alzheimers Dis. 2021;8:371-386. doi:10.14283/jpad.2021.23Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission.
More news about: Eli Lilly and Company
Sep 09, 2025, 07:45 ET Modeyso™ (dordaviprone) Included in National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for H3 K27M-mutant Diffuse Glioma
Details | ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) | ClinicalTrials.gov5 Bagley, S. J., Umemura, et al. Prognostic Features of Recurrent Midline and H3 K27M-Mutant Glioma. Cancers. 2025;17(13):2107.
More news about: Jazz Pharmaceuticals plc
Sep 09, 2025, 07:30 ET Conagra Brands Foundation Awards Grants to 21 Local Nonprofits Through "Nourish Our Community" Program
the Conagra Brands Foundation will provide approximately 1,380 meals over three days of service.Nominated by Conagra Brand employee: Susan J. – Omaha, NE ALL PEOPLE'S PANTRY (NE)Project: Fall/Winter DistributionSupport
More news about: Conagra Brands, Inc.
Sep 09, 2025, 03:30 ET DeuterOncology to Present Promising Phase I DO-2 MET Kinase Inhibitor Data at WCLC 2025
Brant Delafontaine MD, Sylvie Rottey MD, PhD, Ingrid Desar MD, PhD, Marthe Paats MD, PhD, Barend J. Sikkema3MD, , Florence Wastelin MSc, Cecilia Ahlin MD PhD, Timothy Perera PhD, Jaap Verweij MD, PhD, Carla van Herpen MD, PhD,
More news about: DeuterOncology
Sep 09, 2025, 00:00 ET Eaton、TD SYNNEXと提携し、日本のAIとエッジコンピューティングインフラの安全性を確保
9PX J UPS」も発表しました。デジタル化が進む未来に向けて、企業の電力レジリエンス強化を支援します。 高い人気を誇る「9PX UPS」をベースにした「9PX J UPS」は、IT、医療、産業オートメーション、教育などのミッションクリティカルな用途に対して、クリーンで途切れない電力を提供します。国際および国内の安全基準を満たしており、ユーザーに安心をもたらします。詳細は
More news about: Eaton
Sep 08, 2025, 20:04 ET AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS
E, Chong C, et al. OX40 in the pathogenesis of atopic dermatitis—a new therapeutic target. Am J Clin Dermatol. 2024;25(3):447-461. doi:10.1007/s40257-023-00838-9. Epub 2024 Jan 18. Erratum in: Am J Clin Dermatol. 2024;25(3):463. doi:10.1007/s40257-024-00850-7. PMID: 38236520; PMCID: PMC11070399. National
More news about: Amgen